AU Stock MarketDetailed Quotes

OSPDA Osprey Medical Inc

Watchlist

0.000
0.0000.00%

20min DelayTrading Jul 24 10:00 AET

0Market Cap0.00P/E (Static)

Osprey Medical Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 30, 2020

(FY)Dec 30, 2019

(FY)Dec 30, 2018

Total revenue

-54.38%1.67M

45.78%3.67M

2.51M

Operating revenue

-54.38%1.67M

45.78%3.67M

--2.51M

Cost of revenue

-30.78%1.22M

27.71%1.77M

1.38M

Gross profit

-76.38%448.18K

67.92%1.9M

1.13M

Operating expense

-30.75%14.14M

5.98%20.42M

19.26M

Selling and administrative expenses

-36.91%9.2M

8.47%14.57M

--13.44M

-Selling and marketing expense

-46.45%5.73M

7.13%10.7M

--9.99M

-General and administrative expense

-10.52%3.46M

12.37%3.87M

--3.45M

Research and development costs

-27.65%2.22M

-15.78%3.06M

--3.64M

Depreciation amortization depletion

8.49%301.68K

1.51%278.07K

--273.92K

-Depreciation and amortization

8.49%301.68K

1.51%278.07K

--273.92K

Other operating expenses

-3.00%2.43M

30.47%2.5M

--1.92M

Operating profit

26.07%-13.69M

-2.13%-18.52M

-18.13M

Net non-operating interest income (expenses)

Other net income (expenses)

-90.78%16.04K

-49.49%173.93K

344.32K

Other non-operating income (expenses)

-90.78%16.04K

-49.49%173.93K

--344.32K

Income before tax

25.98%-13.37M

-3.15%-18.07M

-17.51M

Income tax

154.00%5.28K

-239.99%-9.77K

6.98K

Earnings from equity interest net of tax

Net income

25.91%-13.38M

-3.05%-18.06M

-17.52M

Net income continuous operations

25.91%-13.38M

-3.05%-18.06M

---17.52M

Noncontrolling interests

Net income attributable to the company

25.91%-13.38M

-3.05%-18.06M

-17.52M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

25.91%-13.38M

-3.05%-18.06M

-17.52M

Diluted earnings per share

86.48%-0.565

16.40%-4.18

-5

Basic earnings per share

86.48%-0.565

16.40%-4.18

-5

Dividend per share

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

	(FY)Dec 30, 2020	(FY)Dec 30, 2019	(FY)Dec 30, 2018
Total revenue	-54.38%1.67M	45.78%3.67M	2.51M
Operating revenue	-54.38%1.67M	45.78%3.67M	--2.51M
Cost of revenue	-30.78%1.22M	27.71%1.77M	1.38M
Gross profit	-76.38%448.18K	67.92%1.9M	1.13M
Operating expense	-30.75%14.14M	5.98%20.42M	19.26M
Selling and administrative expenses	-36.91%9.2M	8.47%14.57M	--13.44M
-Selling and marketing expense	-46.45%5.73M	7.13%10.7M	--9.99M
-General and administrative expense	-10.52%3.46M	12.37%3.87M	--3.45M
Research and development costs	-27.65%2.22M	-15.78%3.06M	--3.64M
Depreciation amortization depletion	8.49%301.68K	1.51%278.07K	--273.92K
-Depreciation and amortization	8.49%301.68K	1.51%278.07K	--273.92K
Other operating expenses	-3.00%2.43M	30.47%2.5M	--1.92M
Operating profit	26.07%-13.69M	-2.13%-18.52M	-18.13M
Net non-operating interest income (expenses)
Other net income (expenses)	-90.78%16.04K	-49.49%173.93K	344.32K
Other non-operating income (expenses)	-90.78%16.04K	-49.49%173.93K	--344.32K
Income before tax	25.98%-13.37M	-3.15%-18.07M	-17.51M
Income tax	154.00%5.28K	-239.99%-9.77K	6.98K
Earnings from equity interest net of tax
Net income	25.91%-13.38M	-3.05%-18.06M	-17.52M
Net income continuous operations	25.91%-13.38M	-3.05%-18.06M	---17.52M
Noncontrolling interests
Net income attributable to the company	25.91%-13.38M	-3.05%-18.06M	-17.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	25.91%-13.38M	-3.05%-18.06M	-17.52M
Diluted earnings per share	86.48%-0.565	16.40%-4.18	-5
Basic earnings per share	86.48%-0.565	16.40%-4.18	-5
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall